Ascendia

  MARKET NEWS

eXmoor Completes Expansion Into Full-Service Cell & Gene Therapy CDMO Partner With Opening of GMP Facilities
Ashland Showcases New Bioresorbable Polymers Technology Platform, Pharmaceutical Products & Solutions
BioXcel Therapeutics Reports Positive Overall Survival Results From Single-Arm, Open-Label Phase 2 Trial of BXCL701 in Patients With Small Cell Neuroendocrine Prostate Cancer
AviadoBio Announces Initiation of Phase 1/2 Clinical Trial Evaluating AVB-101 in People With Frontotemporal Dementia With GRN Mutations
MBX Biosciences Doses First Participant in Phase 1/2 Clinical Trial for the Treatment of Post-Bariatric Hypoglycemia
Salubris Biotherapeutics Presents Positive 6-Month Data From Phase 1b Clinical Trial of JK07

  FEATURED EDITORIAL

  COMPANY PROFILE

BD is a reliable partner that can provide expertise in highly specific fields to support your drug throughout its lifecycle, from development to launch and beyond. The company is committed to building partnerships with pharmaceutical and biotechnology companies and developing product solutions that meet their needs by leveraging our innovative technologies, extensive global manufacturing, and advanced technical, scientific, medical, and regulatory expertise. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Nemera Extends Manufacturing Capabilities in North America

Nemera Extends Manufacturing Capabilities in North America

With a newly acquired space in Vernon Hills, IL, Nemera opens a third location in the United States, in addition to the manufacturing facility in Buffalo Grove and Innovation center in Chicago….

Conduit Pharmaceuticals Partners With ClinConnect on Cocrystal Development Program

Conduit Pharmaceuticals Partners With ClinConnect on Cocrystal Development Program

Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed Phase 1 trials….

Olema Oncology Announces Expansion of Collaboration Agreement With Novartis

Olema Oncology Announces Expansion of Collaboration Agreement With Novartis

Olema Pharmaceuticals, Inc. recently announced an amendment to its existing clinical collaboration and supply agreement with Novartis Institutes for BioMedical Research, Inc. to increase the size of….

Sharp Acquires Berkshire Sterile Manufacturing

Sharp Acquires Berkshire Sterile Manufacturing

Sharp recently announced the acquisition of Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish contract development and manufacturing organization (CDMO) for….

  WHITEPAPERS & WEBINARS

WEBINAR - Nanoparticle Suspensions: History, Applications & CMC Aspects

WEBINAR - Nanoparticle Suspensions: History, Applications & CMC Aspects

This webinar describes the history, CMC aspects, and potential applications of nanoparticle suspensions (NSs). This drug delivery technology should be considered for crystalline, sparingly water-soluble APIs. The presentation highlights….

WEBINAR - Beyond the Lab: Unleashing the Potential of In Silico Modeling in Drug Product Formulation

WEBINAR - Beyond the Lab: Unleashing the Potential of In Silico Modeling in Drug Product Formulation

In this webinar you will learn how digital chemistry tools facilitate rapid screening of formulation parameters, aiding in the identification of optimal drug delivery systems, excipient selection, and dosage forms….

WEBINAR - Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing

WEBINAR - Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing

Join us for an upcoming webinar that delves into a crucial issue in the pharmaceutical industry. Recent research has revealed a surprising fact: the pharmaceutical sector has a larger carbon footprint than even the automotive industry, especially when we consider the entire supply chain’s impact on

  WHITEPAPERS & WEBINARS

WHITEPAPER - Accelerate Preclinical Developments & Improve Oral Bioavailability With Lipid-Based Formulation & Encapsulation Technology Combination

WHITEPAPER - Accelerate Preclinical Developments & Improve Oral Bioavailability With Lipid-Based Formulation & Encapsulation Technology Combination

Owing its convenience, oral administration is patients’ preferred route of delivery for therapeutic molecules. However, most New Chemical Entities (NCE) exhibit physico-chemical properties limiting their absorption in the gastro-intestinal (GI) tract. Indeed, according to Pharmacircle data from March 2022, almost …

WHITEPAPER - Improving API Solubility by Salt & Cocrystal Formation

WHITEPAPER - Improving API Solubility by Salt & Cocrystal Formation

Ensuring sufficient solubility is critical to the success of small molecule drugs. An active pharmaceutical ingredient (API) must be absorbed by the body and enter the systemic circulation to deliver the desired therapeutic effect. Many APIs, however, suffer from low …

WHITEPAPER - Streamline Early-Stage Development to Reach the Clinic Faster

WHITEPAPER - Streamline Early-Stage Development to Reach the Clinic Faster

Early-stage development is critical to shortening your product’s timelines while establishing a solid foundation for clinical trials. In this insightful article from Dr. Srinivasan Shanmugam, Adare’s Executive Director of Pharmaceutical Sciences, learn what’s needed to make your product’s early-stage development …

WHITEPAPER - The Viscosity Reduction Platform: Viscosity-Reducing Excipients for Protein Formulation

WHITEPAPER - The Viscosity Reduction Platform: Viscosity-Reducing Excipients for Protein Formulation

Protein viscosity is one of the major obstacles in preparing highly concentrated protein formulations suitable for subcutaneous (subQ) injection. SubQ application of highly concentrated protein formulations enables a higher patient convenience and might thus lead to reduction in health costs. …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 25 – Transdermal/Topical Delivery
November 1 – Formulation Development